COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial.
COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial.
复制标题
DOI：
10.1136/bmjopen-2020-046436
复制
发表时间：
2021-05-26
期刊：
影响因子：
2.9
通讯作者：
Romanczuk L
中科院分区：
文献类型：
--
作者：
Richards DA;Sugg HV;Cockcroft E;Cooper J;Cruickshank S;Doris F;Hulme C;Logan P;Iles-Smith H;Melendez-Torres GJ;Rafferty AM;Reed N;Russell AM;Shepherd M;Singh SJ;Thompson Coon J;Tooze S;Wootton S;Abbott R;Bethel A;Creanor S;Quinn L;Tripp H;Warren FC;Whear R;Bollen J;Hunt HA;Kent M;Morgan L;Morley N;Romanczuk L
患者的护理体验与安全性、临床有效性、护理质量、治疗效果和服务使用相关。有效的护理包括发展护患关系和为患者提供身体和心理社会护理的行动。SARS-CoV-2病毒传播的高风险损害了护理。目前尚无针对SARS-CoV-2感染患者的循证护理指南，这可能导致患者体验、结局、质量和成本的变化。我们的目标是从14家英国医院招募840名因SARS-CoV-2病毒感染而接受治疗的住院患者参与一项群集随机对照试验，该试验包括嵌入式流程和经济评估，对常规护理和基础护理方案进行评估，该方案涉及与常规护理相比可能发生潜在变化的身体、关系和心理社会护理的特定领域。我们的共同主要结局是患者报告的经验（从患者角度看质量;护理问卷的关系方面）;次要结局包括护理质量（压伤、福尔斯、用药错误）;功能能力（Barthell指数）;治疗结局（WHO临床进展量表）;抑郁症患者健康问卷-2（PHQ-2）、焦虑症广泛性焦虑障碍-2（GAD-2）、健康效用（EQ 5D）和护士报告的结果（医疗保健专业人员道德困扰的测量）。对于我们的主要分析，我们将使用标准的广义线性混合效应模型，在聚类水平上调整患者样本的种族和研究强度。我们还将进行计划的亚组分析，以比较患者水平的种族对我们的主要和次要结局的影响，并将进行过程和经济评估。研究管理和伦理批准来自英国国家卫生服务健康研究管理局研究伦理服务。传播将通过同行评审的科学期刊、研究网站、新闻和在线媒体开放获取，包括开放大学FutureLearn网络平台上的免费在线培训材料。ISRCTN 13177364;预结果。
Patient experience of nursing care is correlated with safety, clinical effectiveness, care quality, treatment outcomes and service use. Effective nursing care includes actions to develop nurse–patient relationships and deliver physical and psychosocial care to patients. The high risk of transmission of the SARS-CoV-2 virus compromises nursing care. No evidence-based nursing guidelines exist for patients infected with SARS-CoV-2, leading to potential variations in patient experience, outcomes, quality and costs. we aim to recruit 840 in-patient participants treated for infection with the SARS-CoV-2 virus from 14 UK hospitals, to a cluster randomised controlled trial, with embedded process and economic evaluations, of care as usual and a fundamental nursing care protocol addressing specific areas of physical, relational and psychosocial nursing care where potential variation may occur, compared with care as usual. Our coprimary outcomes are patient-reported experience (Quality from the Patients’ Perspective; Relational Aspects of Care Questionnaire); secondary outcomes include care quality (pressure injuries, falls, medication errors); functional ability (Barthell Index); treatment outcomes (WHO Clinical Progression Scale); depression Patient Health Questionnaire-2 (PHQ-2), anxiety General Anxiety Disorder-2 (GAD-2), health utility (EQ5D) and nurse-reported outcomes (Measure of Moral Distress for Health Care Professionals). For our primary analysis, we will use a standard generalised linear mixed-effect model adjusting for ethnicity of the patient sample and research intensity at cluster level. We will also undertake a planned subgroup analysis to compare the impact of patient-level ethnicity on our primary and secondary outcomes and will undertake process and economic evaluations. Research governance and ethical approvals are from the UK National Health Service Health Research Authority Research Ethics Service. Dissemination will be open access through peer-reviewed scientific journals, study website, press and online media, including free online training materials on the Open University’s FutureLearn web platform. ISRCTN13177364; Pre-results.
登录
查看更多内容
影响因子：
168.9
作者：
Aiken, Linda H.;Sloane, Douglas M.;Bruyneel, Luk;Van den Heede, Koen;Griffiths, Peter;Busse, Reinhard;Diomidous, Marianna;Kinnunen, Juha;Kozka, Maria;Lesaffre, Emmanuel;McHugh, Matthew D.;Moreno-Casbas, M. T.;Rafferty, Anne Marie;Schwendimann, Rene;Scott, P. Anne;Tishelman, Carol;van Achterberg, Theo;Sermeus, Walter
通讯作者：
Sermeus, Walter
影响因子：
105.7
作者：
Campbell, MK;Elbourne, DR;Altman, DG
通讯作者：
Altman, DG
影响因子：
2.9
作者：
Doyle C;Lennox L;Bell D
通讯作者：
Bell D
影响因子：
--
作者：
Epstein, Elizabeth G;Whitehead, Phyllis B;Hamric, Ann B
通讯作者：
Hamric, Ann B
影响因子：
4
作者：
Gale NK;Heath G;Cameron E;Rashid S;Redwood S
通讯作者：
Redwood S